Novel Adjuvant Therapies for Lung Cancer

Lung cancer is one of the most fatal types of cancer, but significant advances are being made. How are novel adjuvant post-operative therapies, including personalized therapies, improving survival and quality of life for patients with lung cancer?

John C. Kucharczuk, MD, assistant professor of surgery and surgeon in the division of thoracic surgery at Penn Medicine, discusses clinical trials centered around adjuvant therapies for patients with lung cancer. Dr. Lee Freedman hosts.



Source: ReachMD | Originally Aired: January 18, 2010 | Length: 13 min